Your right Shelly! Pfizer has former head of the FDA Scott Gottlieb on their board. I think he knows the process and how to get an approval. It’s not always what you got... its who you know and what you know. Hopefully our newly hired Chief Science officer sets our path up for success like he has done in other biotechs. Once We are successful in our next attempt at a BLA, maybe we get this done in short order for HIV? Maybe Covid happens sooner than later. Before more drugs hit the market before us. All though I believe there is plenty of room for many therapeutics and we are in a class by ourselves being in the Severe/Critical group.

When the Pfizer vaccine or the Eli Lilly MAB is given to late to be effective for Covid, then what MAB will they be reaching for next? Hopefully Leronlimab! Leronlimab has its place all marked out in severe/critical and hopefully Long Haulers. Can’t fill this trial any faster for me to be happy.

I do hope that when Nader said he will apply for a 14 day review instead of waiting 42 days that it happens this way. The major majority of patients will be past the 42 days Morbidity time he said. I am still hoping if the 14 day review happens.

Then we’re looking for a nice Christmas EUA for everyone. I know I am pushing it. But sometimes you just have to keep the faith. Sometimes all you have is faith left to count on. I have faith in our path.

GLTU